156 related articles for article (PubMed ID: 35627203)
1. The Deubiquitinase USP39 Promotes Esophageal Squamous Cell Carcinoma Malignancy as a Splicing Factor.
Zhu X; Ma J; Lu M; Liu Z; Sun Y; Chen H
Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627203
[TBL] [Abstract][Full Text] [Related]
2. The Deubiquitinase USP39 Promotes ESCC Tumorigenesis Through Pre-mRNA Splicing of the mTORC2 Component Rictor.
Zhao Y; Geng H; Liu G; Ji Q; Cheng X; Li X; Liu W; Thorne RF; Zhang R; Liu X
Front Oncol; 2021; 11():667495. PubMed ID: 34123832
[TBL] [Abstract][Full Text] [Related]
3. Splicing factor USP39 promotes ovarian cancer malignancy through maintaining efficient splicing of oncogenic HMGA2.
Wang S; Wang Z; Li J; Qin J; Song J; Li Y; Zhao L; Zhang X; Guo H; Shao C; Kong B; Liu Z
Cell Death Dis; 2021 Mar; 12(4):294. PubMed ID: 33731694
[TBL] [Abstract][Full Text] [Related]
4. USP39 Promotes the Viability and Migration of Head and Neck Squamous Cell Carcinoma Cell by Regulating STAT1.
Hu Y; Wang Y; Hu W; Hu C; Wang B; Liu C; Deng A; Shen B; Wu K; Liu Y
Technol Cancer Res Treat; 2024; 23():15330338241250298. PubMed ID: 38706215
[No Abstract] [Full Text] [Related]
5. USP39 Deubiquitinase Is Essential for
Fraile JM; Manchado E; Lujambio A; Quesada V; Campos-Iglesias D; Webb TR; Lowe SW; López-Otín C; Freije JM
J Biol Chem; 2017 Mar; 292(10):4164-4175. PubMed ID: 28154181
[No Abstract] [Full Text] [Related]
6. USP39 promotes hepatocellular carcinogenesis through regulating alternative splicing in cooperation with SRSF6/HNRNPC.
Zheng J; Wu S; Tang M; Xi S; Wang Y; Ren J; Luo H; Hu P; Sun L; Du Y; Yang H; Wang F; Gao H; Dai Z; Ou X; Li Y
Cell Death Dis; 2023 Oct; 14(10):670. PubMed ID: 37821439
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of USP39 induces cell cycle arrest and apoptosis in melanoma.
Zhao Y; Zhang B; Lei Y; Sun J; Zhang Y; Yang S; Zhang X
Tumour Biol; 2016 Oct; 37(10):13167-13176. PubMed ID: 27456357
[TBL] [Abstract][Full Text] [Related]
8. USP39 mediates p21-dependent proliferation and neoplasia of colon cancer cells by regulating the p53/p21/CDC2/cyclin B1 axis.
Yuan J; Li X; Zhang G; Cheng W; Wang W; Lei Y; Ma Q; Song G
Mol Carcinog; 2021 Apr; 60(4):265-278. PubMed ID: 33634905
[TBL] [Abstract][Full Text] [Related]
9. USP39, a direct target of microRNA-133a, promotes progression of pancreatic cancer via the AKT pathway.
Cai J; Liu T; Huang P; Yan W; Guo C; Xiong L; Liu A
Biochem Biophys Res Commun; 2017 Apr; 486(1):184-190. PubMed ID: 28286270
[TBL] [Abstract][Full Text] [Related]
10. USP39 interacts with SIRT7 to promote cervical squamous cell carcinoma by modulating autophagy and oxidative stress via FOXM1.
Yu J; Yuan S; Song J; Yu S
J Transl Med; 2023 Nov; 21(1):807. PubMed ID: 37957720
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of ubiquitin‑specific peptidase 39 inhibits the malignant progression of human renal cell carcinoma.
Xu Y; Zhu MR; Zhang JY; Si GM; Lv JJ
Mol Med Rep; 2018 Mar; 17(3):4729-4735. PubMed ID: 29328477
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of USP39 by lentivirus-mediated RNA interference suppresses the growth of oral squamous cell carcinoma.
Li KY; Zhang J; Jiang LC; Zhang B; Xia CP; Xu K; Chen HY; Yang QZ; Liu SW; Zhu H
Cancer Biomark; 2016; 16(1):137-144. PubMed ID: 26835714
[TBL] [Abstract][Full Text] [Related]
13. USP39 promotes the growth of human hepatocellular carcinoma in vitro and in vivo.
Yuan X; Sun X; Shi X; Jiang C; Yu D; Zhang W; Guan W; Zhou J; Wu Y; Qiu Y; Ding Y
Oncol Rep; 2015 Aug; 34(2):823-32. PubMed ID: 26081192
[TBL] [Abstract][Full Text] [Related]
14. Lentivirus mediated silencing of ubiquitin specific peptidase 39 inhibits cell proliferation of human hepatocellular carcinoma cells in vitro.
Pan Z; Pan H; Zhang J; Yang Y; Liu H; Yang Y; Huang G; Ni J; Huang J; Zhou W
Biol Res; 2015 Mar; 48(1):18. PubMed ID: 25889525
[TBL] [Abstract][Full Text] [Related]
15. RNA splicing factor USP39 promotes glioma progression by inducing TAZ mRNA maturation.
Ding K; Ji J; Zhang X; Huang B; Chen A; Zhang D; Li X; Wang X; Wang J
Oncogene; 2019 Sep; 38(37):6414-6428. PubMed ID: 31332287
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin-specific peptidase 39 regulates the process of proliferation and migration of human ovarian cancer via p53/p21 pathway and EMT.
Yan C; Yuan J; Xu J; Zhang G; Li X; Zhang B; Hu T; Huang X; Mao Y; Song G
Med Oncol; 2019 Oct; 36(11):95. PubMed ID: 31637536
[TBL] [Abstract][Full Text] [Related]
17. Starvation-induced suppression of DAZAP1 by miR-10b integrates splicing control into TSC2-regulated oncogenic autophagy in esophageal squamous cell carcinoma.
Chen Y; Lu Y; Ren Y; Yuan J; Zhang N; Kimball H; Zhou L; Yang M
Theranostics; 2020; 10(11):4983-4996. PubMed ID: 32308763
[TBL] [Abstract][Full Text] [Related]
18. USP39 Serves as a Deubiquitinase to Stabilize STAT1 and Sustains Type I IFN-Induced Antiviral Immunity.
Peng Y; Guo J; Sun T; Fu Y; Zheng H; Dong C; Xiong S
J Immunol; 2020 Dec; 205(11):3167-3178. PubMed ID: 33127822
[TBL] [Abstract][Full Text] [Related]
19. USP39 regulates the cell cycle, survival, and growth of human leukemia cells.
Liu C; Yao X; Li M; Xi Y; Zhao L
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30898977
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA DGCR5 involves in tumorigenesis of esophageal squamous cell carcinoma via SRSF1-mediated alternative splicing of Mcl-1.
Duan Y; Jia Y; Wang J; Liu T; Cheng Z; Sang M; Lv W; Qin J; Liu L
Cell Death Dis; 2021 Jun; 12(6):587. PubMed ID: 34099633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]